ApoB and LDL cholesterol measure related but different things. LDL cholesterol tells you how much cholesterol is carried in LDL particles, while ApoB counts the number of atherogenic particles themselves. In most people the two agree. In some, particularly with raised triglycerides, diabetes or a larger waist, ApoB runs higher than LDL suggests, and that gap can matter for long-term risk.
Key points
In the CARDIA study of 2,794 young adults, published in the Journal of the American College of Cardiology in 2016, a high ApoB with a low LDL cholesterol was linked to coronary artery calcium 25 years later.
A 2025 UK Biobank analysis of 375,544 adults in the European Journal of Preventive Cardiology found a discordantly high ApoB carried an 11 percent higher risk of major cardiovascular events.
NICE guideline NG238, published in 2023, bases routine UK risk assessment on QRISK3 and non-HDL cholesterol rather than ApoB.
European Society of Cardiology guidance recommends ApoB in people with raised triglycerides, diabetes, obesity or very low LDL cholesterol.
Ask a doctor about an ApoB review on WhatsApp&type=phone_number&app_absent=0) or email team@thewellnesslondon.com.
What does ApoB measure?
Every particle that can lodge in an artery wall and start plaque carries exactly one molecule of apolipoprotein B on its surface. That includes LDL, the remnants of VLDL, and lipoprotein(a). Measuring ApoB in the blood is therefore close to a direct count of the particles that cause atherosclerosis.
LDL cholesterol is different. It is an estimate of the mass of cholesterol carried inside LDL particles, usually calculated from total cholesterol, HDL and triglycerides rather than measured directly. Two people can have the same LDL cholesterol while one carries it in a modest number of large particles and the other in many small ones.
That distinction is the whole point of the test. Particle number, not the cholesterol cargo, is what drives particles into the artery wall. A 2019 narrative review in JAMA Cardiology by Sniderman and colleagues set out this argument in detail and concluded that ApoB is the more accurate marker of the atherogenic burden.
For most people the distinction is academic, because the two numbers rise and fall together. The test earns its place when they come apart.
Why can LDL cholesterol and ApoB tell different stories?
Discordance happens when the cholesterol content per particle changes. When triglycerides are raised, LDL particles tend to become smaller and carry less cholesterol each. The LDL cholesterol figure then looks reassuring while the particle count stays high.
The pattern is common in the metabolic picture many professionals recognise. Insulin resistance, type 2 diabetes, fatty liver, a larger waist and high triglycerides all push in this direction. It also appears in people with low HDL cholesterol.
The reverse happens too. Some people have a high LDL cholesterol carried in relatively few large particles, so their ApoB is lower than expected. The 2025 UK Biobank analysis found this discordantly low group had a 13 percent lower risk of major events than people whose two results agreed.
This is why a single LDL figure can mislead in either direction. It is also why a doctor reviewing your results looks at triglycerides, HDL, non-HDL cholesterol, glucose and blood pressure together, rather than at one number in isolation.
What does the evidence show about discordance?
The strongest data come from large cohorts rather than randomised trials, which is an honest limit worth stating at the outset.
In the CARDIA study, 2,794 adults aged 18 to 30 had ApoB measured at baseline and a heart scan for coronary artery calcium 25 years later. Higher ApoB tertiles carried odds ratios of 1.53 and 2.28 for calcium compared with the lowest tertile. A high ApoB with a low LDL cholesterol still carried an odds ratio of 1.55 after adjustment for traditional risk factors.
The 2025 UK Biobank work followed 375,544 adults without heart disease who were not taking lipid-lowering medicine. Those with a discordantly high ApoB had a hazard ratio of 1.11 for major cardiovascular events. Around a quarter of that excess risk was explained by triglyceride-rich particles.
Mendelian randomisation studies, which use genetic variation as a natural experiment, point the same way. Particle number appears to be the causal driver, which is why ApoB tends to outperform LDL cholesterol when the two disagree.
What the evidence does not yet show is that routinely testing everyone and treating to an ApoB target improves outcomes beyond current UK practice. That trial has not been done.
Book a free doctor-led review of your cholesterol results&type=phone_number&app_absent=0)
When might an ApoB discussion be useful?
ApoB adds most where the standard numbers are likely to underestimate risk. Our doctors raise it in these situations.
Triglycerides above around 2 mmol per litre, where calculated LDL becomes less reliable.
Type 2 diabetes, prediabetes or insulin resistance.
A larger waist, fatty liver or the metabolic syndrome.
A very low LDL cholesterol on treatment, where residual risk needs a better measure.
A strong family history of early heart disease with reassuring standard results.
Lipoprotein(a) results or other markers that leave the picture unclear.
ApoB is less useful when every other number is clearly low and you have no other risk factors, because a high result is then unlikely and would rarely change the plan. Testing should answer a question, not add a number for its own sake.
A free self-check before you test
This is a short checklist you can run from your last routine blood test, whoever ordered it. It tells you whether an ApoB result is likely to change anything.
Look at your triglycerides. A fasting value above 1.7 mmol per litre makes discordance more likely, and above 2 mmol per litre makes it common.
Work out your non-HDL cholesterol by subtracting HDL from total cholesterol. A value above 4 mmol per litre deserves a conversation even if LDL looks acceptable.
Check your HbA1c. A value of 42 mmol per mol or higher marks prediabetes, and 48 or higher is in the diabetic range.
Measure your waist at the level of your navel. Above 94 cm for men or 80 cm for women raises metabolic risk, with lower thresholds for South Asian adults.
Note any parent or sibling with a heart attack or stroke before 55 in men or 65 in women.
If two or more of these apply, an ApoB result is likely to add useful information. If none apply, your standard results are probably telling the full story.
Does ApoB replace the usual UK prevention assessment?
No. In England, NICE guideline NG238 sets out cardiovascular risk assessment using the QRISK3 calculator, which combines age, sex, ethnicity, blood pressure, cholesterol ratio, smoking, diabetes and other factors into a 10-year risk. Treatment decisions follow that score and non-HDL cholesterol.
ApoB sits alongside that framework rather than replacing it. The European Society of Cardiology and European Atherosclerosis Society recommend ApoB for risk assessment in people with high triglycerides, diabetes, obesity or very low LDL cholesterol, and suggest it as an alternative treatment target in those groups.
In practice, a doctor uses ApoB to refine a borderline decision. Someone with a QRISK3 score just below the treatment threshold and a high ApoB may reasonably start a statin sooner. Someone with a high LDL but a low ApoB may reasonably focus on lifestyle first. Neither decision rests on ApoB alone.
As our doctors put it, "A cholesterol number is only useful if it changes what you do next. ApoB earns its place when the usual numbers leave real doubt."
How is a raised result interpreted?
There is no single UK cut-off printed on every laboratory report, so interpretation depends on context. European guidance uses ApoB targets that fall as overall risk rises, broadly mirroring the LDL targets for each risk category.
A doctor reviewing a raised ApoB will first repeat or confirm it if the result is unexpected, and check for causes that are easy to miss. An underactive thyroid, kidney disease, some medicines and uncontrolled diabetes can all push lipids up.
The next step is to place the result within your full risk. That means QRISK3, blood pressure, smoking status, family history and, where relevant, lipoprotein(a). In selected people, a coronary artery calcium scan can help decide whether treatment is worthwhile.
Management usually starts with the same measures that lower triglycerides and particle number. Reducing refined carbohydrate and alcohol, losing weight around the waist and regular exercise all reduce ApoB. Where medicine is needed, statins lower ApoB substantially, and your GP can continue the plan.
What ApoB testing does not do
A single ApoB result does not diagnose heart disease or tell you whether a plaque is present. It is a risk marker, not a scan.
It does not replace QRISK3, blood pressure checks or a conversation about smoking, which together account for far more of your risk than any one lipid number.
It is not a reason to start medicine on its own. Treatment decisions in the UK still follow overall risk, and ApoB refines them at the margins.
The evidence for discordance comes mostly from observational cohorts. They are large and consistent, but they show association. No randomised trial has yet shown that treating to an ApoB target improves outcomes beyond current care.
Finally, ApoB is not a hair or skin test. If you came to this article from a hair loss search, the bloods that matter for shedding are ferritin, thyroid function, vitamin D, B12 and folate, which we cover in our guide to blood tests before hair PRP.
What does a cholesterol and ApoB review cost in London?
Basic private blood checks in London typically cost £169 to £400. Comprehensive screening packages sit much higher, with Bupa's comprehensive assessment at £1,199 and Nuffield's 360 assessment around £1,129. Central London executive health assessments commonly run from £3,500 to £8,000.
The difference between these tiers is rarely the blood test itself. It is whether a doctor interprets the results against your full risk and tells you what to do next. A panel that arrives as a list of numbers with no plan is a different product from a review that ends with a decision.
Our care is doctor-led and priced below flagship rates. The exact figure for the panel and the review is confirmed at your free suitability review, once a doctor has agreed which tests will answer your question. We do not sell markers by the dozen.
Message us about an ApoB and lipid review&type=phone_number&app_absent=0) or email team@thewellnesslondon.com.
Your free suitability review
Every enquiry starts with a free doctor-led suitability review rather than a booking. A GMC-registered doctor assesses you and gives one of two answers. Approved for treatment, with a clear plan and realistic expectations, or not approved, with an honest explanation of what would serve you better. We decline a meaningful share of enquiries, because treating someone who will not benefit helps nobody.
For a cholesterol question, the review looks at your existing results first. If an ApoB result would not change your plan, the doctor will tell you so, and you will not be asked to pay for a test you do not need.
Why people choose The London PRP Clinic by The Wellness
87 percent patient success rate across our treatment outcomes.
32 percent average density increase in hair restoration.
More than 187 five-star reviews.
Every treatment is performed by a GMC-registered doctor.
100 supervised treatments before any clinician treats a patient here.
Our blood-test-first approach means a doctor reads your results before any treatment is discussed, whether the question is your heart, your hair or your joints.
Start with a free suitability review on WhatsApp&type=phone_number&app_absent=0)
Frequently asked questions
What is the difference between ApoB and LDL cholesterol?
LDL cholesterol measures the amount of cholesterol carried in LDL particles. ApoB counts the particles themselves, because each harmful particle carries one ApoB molecule. When particles are small and numerous, ApoB can be high while LDL cholesterol looks normal.
Is ApoB a better predictor of heart disease than LDL?
When the two disagree, ApoB tends to predict risk better. A UK Biobank analysis of 375,544 adults found a discordantly high ApoB carried an 11 percent higher risk of major events. When they agree, both give similar information.
Does the NHS test ApoB?
ApoB is not part of routine NHS cardiovascular checks. NICE guideline NG238 uses QRISK3 and non-HDL cholesterol for risk assessment. Some lipid clinics measure ApoB for specific patients, and it is widely available privately.
Who should consider an ApoB test?
People with raised triglycerides, diabetes or prediabetes, a larger waist, fatty liver, a very low LDL on treatment, or a strong family history with reassuring standard results benefit most. A doctor can tell you whether it would change your plan.
Do I need to fast for an ApoB test?
ApoB is not significantly affected by a recent meal, so fasting is usually unnecessary. If triglycerides are measured at the same time, your doctor may still ask you to fast so the full lipid profile can be compared fairly.
Can I lower my ApoB without medicine?
Yes, in many people. Cutting refined carbohydrate and alcohol, losing weight around the waist and regular exercise lower triglycerides and particle number. Where overall risk is high, a statin lowers ApoB substantially, and a doctor will discuss whether you need one.
This article is general information and does not replace a consultation with a doctor. If you have sudden severe pain, a hot swollen joint, fever or rapidly spreading redness, seek urgent medical care or call 999.
Reviewed by [GMC-REGISTERED DOCTOR NAME, GMC NUMBER TO CONFIRM], The London PRP Clinic by The Wellness. Last updated November 2026.